XML 28 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 11 - Stock Awards
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11.
STOCK AWARDS
 
In accordance with Bancshares’
2013
Incentive Plan, stock awards, including stock options and restricted stock, have been granted to certain employees and non-employee directors. Shares of common stock available for distribution to satisfy the grants
may
consist, in whole or in part, of authorized and unissued shares, treasury shares or shares reacquired by the Company in any manner.  Stock-based compensation expense related to stock awards totaled
$0.2
million and
$0.1
million for the
nine
-month periods ended
September 30, 2017
and
2016,
respectively.
 
Stock Options
 
The stock option awards were granted with an exercise price equal to the market price of Bancshares’ common stock on the date of the grant and have vesting periods ranging from
one
to
three
years, with
10
-year contractual terms.
 
The Company recognizes the cost of services received in exchange for stock option awards based on the grant date fair value of the award, with compensation expense recognized on a straight-line b
asis over the award’s vesting period. The fair value of outstanding awards was determined using the Black-Scholes option pricing model based on the assumptions noted in the table below. Expected volatilities are based on historical volatilities of Bancshares’ common stock.
 
   
2017
   
2016
 
Risk-free interest rate    
2.23
%    
1.58
%
Expected term  
7.5 years
   
7.5 years
 
Expected stock price volatility    
25.36
%    
25.25
%
Dividend yield    
1.50
%    
1.50
%
 
The following table summarizes the Company's stock option activity for the periods presented.
 
   
Nine
Months Ended
 
   
September 30
, 2017
   
September 30
, 2016
 
   
Number of
Shares
   
Average
Exercise
Price
   
Number of
Shares
   
Average
Exercise
Price
 
Options:
                               
Outstanding, beginning of period
   
272,550
    $
8.21
     
175,550
    $
8.17
 
Granted
   
70,600
     
13.84
     
97,000
     
8.30
 
Exercised
   
19,316
     
8.15
     
     
 
Expired
   
     
     
     
 
Forfeited
   
3,334
     
11.79
     
     
 
Options outstanding, end of period
   
320,500
    $
9.42
     
272,550
    $
8.21
 
Options exercisable, end of period
   
208,633
    $
8.20
     
175,550
    $
8.17
 
 
The aggregate intrinsic value of stock options outstanding (calculated as the
amount by which the market value of underlying stock exceeds the exercise price of the option) was approximately
$0.8
million and
$0.4
million as of
September 30, 2017
and 
2016,
respectively.
 
Restricted Stock
 
During the
first
nine
months of
2017,
7,533
shares of restricted stock were granted with vesting periods of either
one
or
three
years. 
No
shares of restricted stock were granted during the
nine
months ended
September 30, 2016.
The Company recognizes the cost of services received in exchange for restricted stock awards based on the grant date closing price of the stock, with compensation expense recognized on a straight-line basis over the award’s vesting period.